This Week in Managed CareCMS Addresses Drug Costs, and Other Health News
This week, the top managed care stories included a new rule from CMS to address drug costs for seniors; a campaign to get payers to fund the artificial pancreas is working; and a new survey identifies how Americans prefer to treat pain.\n\nRead more about the stories in this podcast:\nNew CMS Rule Takes Aim at Drug Costs for Seniors, Opioid Crisis: www.ajmc.com/focus-of-the-week/new-cms-rule-takes-aim-at-drug-costs-for-seniors-opioid-crisis\n\nJDRF Announces Anthem Policy Change on Medtronic Artificial Pancreas: www.ajmc.com/newsroom/jdrf-announces-anthem-policy-change-on-medtronic-artificial-pancreas\n\nSurvey Identifies Americans' Preferences for Pain Management: www.ajmc.com/newsroom/survey-identifies-americans-preferences-for-pain-management\n\nASCO's TAPUR Study Expands to Enroll Patients Receiving Immunotherapy: www.ajmc.com/newsroom/ascos-tapur-study-expands-to-enroll-patients-receiving-immunotherapy\n\nChanges in Cardiovascular Care Provision After the Affordable Care Act: www.ajmc.com/journals/issue/2017/2017-vol23-n11/changes-in-cardiovascular-care-provision-after-the-affordable-care-act